Cernostics nets $5 mln
UPMC Enterprises is leading a $5 million round for Pittsburgh and Bethlehem, Pennsylvania-based Cernostics, a cancer diagnostics company. Other investors in the round include Novitas Capital.
31 August 2016•4 mins read
UPMC Enterprises is leading a $5 million round for Pittsburgh and Bethlehem, Pennsylvania-based Cernostics, a cancer diagnostics company. Other investors in the round include Novitas Capital.
